Sunmax Biotechnology Co Ltd (4728) — Cash Flow Quality Index
Sunmax Biotechnology Co Ltd (4728) has a Cash Flow Quality Index of 0.85x as of September 2025. Operating cash flow of NT$160.84 Million is below net income of NT$189.68 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore investment intensity of Sunmax Biotechnology Co Ltd to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sunmax Biotechnology Co Ltd Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Sunmax Biotechnology Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 4728 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Sunmax Biotechnology Co Ltd (2016–2024)
Year-by-year earnings quality comparison for Sunmax Biotechnology Co Ltd. For live market cap and the full company financial profile, see 4728 company net worth.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.58x | NT$397.37 Million | NT$679.40 Million | ▼ -37.3% |
| 2023 | 0.93x | NT$848.56 Million | NT$909.39 Million | ▲ +45.2% |
| 2022 | 0.64x | NT$342.97 Million | NT$533.83 Million | ▼ -5.6% |
| 2021 | 0.68x | NT$243.28 Million | NT$357.49 Million | ▼ -40.6% |
| 2020 | 1.15x | NT$386.97 Million | NT$337.76 Million | ▼ -60.2% |
| 2019 | 2.88x | NT$289.51 Million | NT$100.45 Million | ▲ +113.4% |
| 2018 | 1.35x | NT$100.83 Million | NT$74.66 Million | ▼ -39.8% |
| 2017 | 2.24x | NT$37.09 Million | NT$16.54 Million | ▼ -76.4% |
| 2016 | 9.51x | NT$16.58 Million | NT$1.74 Million | — |